Literature DB >> 27721623

Solitary fibrous tumor of maxilla: A rare entity.

R Heera1, M Renu Chandran1, S K Padmakumar1, R Rajeev1.   

Abstract

Solitary fibrous tumor (SFT) is a ubiquitous rare mesenchymal neoplasm. Pleura is the favored site of origin and is rare in the oral cavity. SFT occurs across a wide histopathologic spectrum. Fibrous form characterized by hyalinized, thick-walled vessels with opened lumina and strong CD34 reactivity constitute one end and on the other end, a cellular form representing the conventional hemangiopericytoma, with branched, thin-walled vessels and focal or negative CD34 reactivity characterize the spectrum. A case of oral SFT in a 30-year-old female patient with its clinical, histopathological and immunohistochemical features is being presented here.

Entities:  

Keywords:  Maxilla; oral cavity; solitary fibrous tumor

Year:  2016        PMID: 27721623      PMCID: PMC5051306          DOI: 10.4103/0973-029X.190960

Source DB:  PubMed          Journal:  J Oral Maxillofac Pathol        ISSN: 0973-029X


INTRODUCTION

Solitary fibrous tumor (SFT) is a rare mesenchymal cell neoplasm that was initially described in the pleura by Lietaud in 1767, followed by Wagner in 1870.[1] The occurrence in the head and neck region are uncommon, accounting for only 6% of all cases.[2] To the best of our knowledge, there are 38 case reports of SFTs originating from the cheek, buccal space or buccal mucosa of the oral cavity in English literature.[3] However, presentation in maxilla is rare, with only a few previously reported cases. SFT and hemangiopericytoma (HPC) are soft tissue tumors with known histologic and immunohistochemical overlap.[4] SFT is preferred by most pathologists as a better term than “HPC” that gathers numerous unrelated entities and is presently employed only by neuropathologists.[5] The fourth edition of the World Health Organization classification of tumors of soft tissue and bone “blue book” published in February 2013 has abandoned the term “HPC”[6] and has grouped SFT, HPC, lipomatous HPC and giant cell angiofibroma under the “extrapleural SFT” category.

CASE REPORT

A 30-year-old female patient was referred to the Department of Oral Pathology, with a history of growth in the upper right molar region for the past 2 months. The mass slowly increased in size with occasional pain and bleeding. Extraorally there was no swelling or trismus. Clinical examination revealed a 5 cm × 5 cm × 3 cm well circumscribed, nodular, nontender, nonfluctuant mass, in relation to the distal aspect of the upper right third molar region extending backward to the pharynx [Figure 1]. The right submaxillary lymph nodes were palpable and tender.
Figure 1

Clinical photograph showing lesion in the right side of maxilla intraorally

Clinical photograph showing lesion in the right side of maxilla intraorally Magnetic resonance imaging showed 3.7 cm × 1.4 cm × 2.2 cm well-defined dumbbell-shaped lesion, occupying the region posterior to right upper 3rd molar tooth. The lesion was hyperintense in T2W1 with widening of the pterygomaxillary fissure and was seen extending laterally. Provisional diagnosis was given by the surgeon as vascular malformation, as the lesion tend to bleed during surgery. Macroscopic examination revealed a firmly circumscribed mass, the cut section of which was gray-white which excluded the clinical diagnosis. Histopathology showed tumor cells arranged around dilated vascular spaces in a storiform pattern [Figure 2]. Alternating zones of hypercellular and hypocellular area were also seen [Figure 3]. Individual tumor cells were round to ovoid and spindle shaped with a moderate amount of eosinophilic cytoplasm and elongated vesicular nucleus with bland chromatin. On the basis of the histopathology, the initial diagnosis was given as soft tissue tumor. However, immunohistochemical studies were done and tumor was diffusely positive for CD34 [Figure 4] and was negative for CD99 [Figure 5], Bcl-2 [Figure 6], vimentin, desmin, S-100 and CD68. These features were consistent with that of SFT, and the final diagnosis was given as SFT.
Figure 2

Endothelial lined dilated blood vessels within the background of a highly cellular and uniform appearing delicately collagenous connective tissue stroma (H&E stain, ×40)

Figure 3

Tumor cells arranged in a storiform pattern and in sheets of alternating hypercellular and hypocellular areas (H&E stain, ×40)

Figure 4

Immunohistochemical staining with CD34 shows diffuse positivity (IHC stain, ×100)

Figure 5

Immunohistochemical staining with CD 99 shows tumor cells to be negative for CD99 (IHC stain, ×100)

Figure 6

Immunohistochemical staining with Bcl 2 shows negative staining (IHC stain, ×40)

Endothelial lined dilated blood vessels within the background of a highly cellular and uniform appearing delicately collagenous connective tissue stroma (H&E stain, ×40) Tumor cells arranged in a storiform pattern and in sheets of alternating hypercellular and hypocellular areas (H&E stain, ×40) Immunohistochemical staining with CD34 shows diffuse positivity (IHC stain, ×100) Immunohistochemical staining with CD 99 shows tumor cells to be negative for CD99 (IHC stain, ×100) Immunohistochemical staining with Bcl 2 shows negative staining (IHC stain, ×40)

DISCUSSION

Klemperer and Rabin in 1931 classified pleural tumors into two types: Diffuse mesotheliomas and localized mesotheliomas or SFT.SFT is one generally associated with serosal surfaces, but in recent years, it has been reported in extrapleural sites such as liver, adrenal glands, skin and less commonly in the head and neck region. Experts suggest that the majority of lesions previously termed HPCs are in fact, SFTs that do not show pericytic differentiation.[7] Ultrastructural and IHC studies of HPC as defined by Enzinger and Smith have suggested that it is a tumor of undifferentiated mesenchymal cells rather than true microvascular pericytes. It has been pointed out that the cells comprising these tumors are fundamentally undifferentiated, and it is only because of their topographic relation to blood vessels and their close association with periendothelial basement membrane, they are inferred as “pericytes.” IHC studies confirmed that actin, a marker of pericytes, was infrequently present in SFTs.[8] SFT occurs mostly in middle-aged adults (between 20 and 60 years) and affects both sex equally. The tumor presents as a slow growing, painless mass. In the present case, histopathology showed ovoid to spindle-shaped tumor cells arranged around dilated vascular spaces in a storiform pattern amidst alternating zones of hypercellular and hypocellular areas. In some zones, the cells are arranged in short, ill-defined fascicles, whereas in others they are arranged randomly in a “patternless pattern.” Although the striking feature of SFT, the characteristic hyalinization,[9] was absent in our case, all other features favored the final diagnosis as SFT. SFT also has a malignant counterpart that shows features such as hypercellularity, high mitotic figures (>4/10 HPF), cytologic atypia, tumor necrosis and infiltrative margins. These features were absent in the present case. SFT of pleural and extrapleural origin typically express CD34 (80–90%), CD99 (70%), Bcl-2 (30%) and EMA (30%). Desmin, cytokeratin and S-100 protein are usually negative.[9] In the present case, microscopy showed spindle cells with a focal pericytic vascular pattern with diffuse CD34 antigen positivity. This excludes the diagnosis of HPC which typically shows staghorn pattern of the vasculature with strong CD34 positivity. Moreover, spindle-shaped cells are absent in HPC.[9] The histopathological diagnosis of this vascularized tumor is challenging, in particular, because of the difficulty in differentiating SFT from other tumors types that have prominent vascularization such as schwannoma, myofibroblastoma, metastasis, spindle-cell carcinoma, low-grade fibromyxoid sarcoma, synovial sarcoma and malignant peripheral nerve sheath tumor.[10]

CONCLUSION

SFT is a rare soft tissue tumor in the head and neck region and rarer in the oral cavity. Many soft tissue lesions in the oral cavity can mimic SFT clinically. SFT resembles many malignant tumors in the head and neck region and should be properly assessed using histopathology. The final diagnosis depends solely on histopathology and immunohistochemistry (IHC). In our case although the clinical diagnosis was vascular malformation, histopathology and IHC favored the diagnosis of SFT. Immunohistochemical staining once again became crucial in establishing the diagnosis of SFT.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

Review 1.  Solitary fibrous tumour and haemangiopericytoma: evolution of a concept.

Authors:  C Gengler; L Guillou
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

2.  Clinicopathologic correlates of solitary fibrous tumors.

Authors:  Jason S Gold; Cristina R Antonescu; Cristina Hajdu; Cristina R Ferrone; Mustafa Hussain; Jonathan J Lewis; Murray F Brennan; Daniel G Coit
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

3.  Orbital hemangiopericytoma and solitary fibrous tumor: a morphologic continuum.

Authors:  J D Goldsmith; M van de Rijn; N Syed
Journal:  Int J Surg Pathol       Date:  2001-10       Impact factor: 1.271

4.  Parotid gland solitary fibrous tumor with mandibular bone destruction and aggressive behavior.

Authors:  Estefanía Alonso-Rodríguez; Teresa González-Otero; Alejandro Castro-Calvo; Elena Ruiz-Bravo; Miguel Burgueño
Journal:  J Clin Exp Dent       Date:  2014-07-01

5.  Solitary fibrous tumors and so-called hemangiopericytoma.

Authors:  Nicolas Penel; Eric Yaovi Amela; Gauthier Decanter; Yves-Marie Robin; Perrine Marec-Berard
Journal:  Sarcoma       Date:  2012-04-08

6.  Hemangiopericytoma/solitaryfibrous tumor of mandible: A rare entity.

Authors:  Samapika Routray; Neeta Mohanty; Swagatika Panda; Sujit Ranjan Sahoo
Journal:  J Oral Maxillofac Pathol       Date:  2015 May-Aug
  6 in total
  1 in total

1.  An Unusual Clinical Presentation of Solitary Fibrous Tumor in the Oral Cavity.

Authors:  Everton Freitas de Morais; Deborah Gondim Lambert Moreira; Viviane Alves De Oliveira; Rodrigo Rodrigues Rodrigues; Adriano Rocha Germano; Roseana de Almeida Freitas
Journal:  Case Rep Pathol       Date:  2017-02-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.